 Katja Kiseljak-Vassiliades
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenocortical Carcinoma | 16 | 2025 | 67 | 6.280 |
Why?
| | Adrenal Cortex Neoplasms | 15 | 2025 | 65 | 5.370 |
Why?
| | Adenoma | 6 | 2025 | 218 | 1.540 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 3 | 2017 | 12 | 1.310 |
Why?
| | Pituitary Neoplasms | 9 | 2025 | 190 | 1.310 |
Why?
| | Cadherins | 2 | 2024 | 201 | 1.160 |
Why?
| | Adrenal Cortex | 4 | 2026 | 33 | 1.090 |
Why?
| | Neuroendocrine Tumors | 2 | 2024 | 112 | 0.900 |
Why?
| | Adrenal Gland Neoplasms | 3 | 2025 | 91 | 0.860 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2024 | 12 | 0.850 |
Why?
| | Pituitary Gland | 4 | 2018 | 148 | 0.750 |
Why?
| | Dehydroepiandrosterone | 1 | 2022 | 50 | 0.720 |
Why?
| | Gene Expression Regulation, Neoplastic | 11 | 2025 | 1455 | 0.700 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4557 | 0.690 |
Why?
| | Androgens | 1 | 2022 | 186 | 0.650 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2020 | 191 | 0.640 |
Why?
| | Tumor Microenvironment | 4 | 2023 | 732 | 0.620 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 128 | 0.590 |
Why?
| | Cell Line, Tumor | 15 | 2026 | 3540 | 0.590 |
Why?
| | Genes, Tumor Suppressor | 3 | 2017 | 83 | 0.590 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2025 | 264 | 0.570 |
Why?
| | Membrane Proteins | 3 | 2025 | 1166 | 0.560 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 40 | 0.520 |
Why?
| | Desmosomes | 1 | 2017 | 22 | 0.520 |
Why?
| | Xenograft Model Antitumor Assays | 6 | 2025 | 928 | 0.490 |
Why?
| | Receptors, Somatostatin | 1 | 2015 | 23 | 0.460 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2015 | 66 | 0.460 |
Why?
| | Drug Repositioning | 2 | 2025 | 41 | 0.440 |
Why?
| | Acromegaly | 1 | 2014 | 16 | 0.430 |
Why?
| | Human Growth Hormone | 1 | 2014 | 46 | 0.410 |
Why?
| | Neurosurgical Procedures | 2 | 2018 | 202 | 0.400 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2020 | 985 | 0.400 |
Why?
| | Antineoplastic Agents | 4 | 2024 | 2194 | 0.390 |
Why?
| | Transcriptome | 4 | 2026 | 1045 | 0.390 |
Why?
| | Mitotane | 2 | 2024 | 10 | 0.380 |
Why?
| | Calcium-Binding Proteins | 2 | 2025 | 219 | 0.340 |
Why?
| | Humans | 41 | 2026 | 144759 | 0.320 |
Why?
| | Apoptosis | 6 | 2021 | 2430 | 0.300 |
Why?
| | Steroidogenic Factor 1 | 2 | 2025 | 12 | 0.290 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 919 | 0.290 |
Why?
| | Cell Proliferation | 7 | 2023 | 2496 | 0.280 |
Why?
| | Mice, Nude | 2 | 2020 | 682 | 0.280 |
Why?
| | Immunotherapy | 3 | 2025 | 653 | 0.270 |
Why?
| | Gene Expression Profiling | 4 | 2026 | 1782 | 0.270 |
Why?
| | Genomics | 2 | 2024 | 834 | 0.260 |
Why?
| | Biomarkers, Tumor | 3 | 2021 | 1313 | 0.250 |
Why?
| | Middle Aged | 12 | 2025 | 35875 | 0.240 |
Why?
| | Fingolimod Hydrochloride | 1 | 2025 | 39 | 0.230 |
Why?
| | Prognosis | 3 | 2022 | 4282 | 0.230 |
Why?
| | Nephritis, Interstitial | 1 | 2025 | 11 | 0.220 |
Why?
| | Sphingolipids | 1 | 2025 | 83 | 0.220 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2025 | 43 | 0.220 |
Why?
| | Sulfasalazine | 1 | 2024 | 22 | 0.220 |
Why?
| | Amino Acid Transport System y+ | 1 | 2024 | 9 | 0.220 |
Why?
| | Mice | 10 | 2025 | 18339 | 0.220 |
Why?
| | Hydrocortisone | 1 | 2026 | 304 | 0.210 |
Why?
| | Immunoconjugates | 1 | 2025 | 132 | 0.200 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2025 | 381 | 0.200 |
Why?
| | Animals | 14 | 2025 | 38058 | 0.200 |
Why?
| | beta Catenin | 1 | 2025 | 252 | 0.190 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2024 | 194 | 0.190 |
Why?
| | Female | 15 | 2026 | 78271 | 0.190 |
Why?
| | MicroRNAs | 2 | 2026 | 701 | 0.190 |
Why?
| | Luteinizing Hormone | 1 | 2023 | 190 | 0.190 |
Why?
| | Anorexia | 1 | 2022 | 17 | 0.180 |
Why?
| | Adult | 11 | 2025 | 40449 | 0.180 |
Why?
| | Wnt Signaling Pathway | 2 | 2021 | 210 | 0.180 |
Why?
| | Aldosterone | 2 | 2019 | 43 | 0.170 |
Why?
| | Cell Cycle Proteins | 2 | 2018 | 628 | 0.170 |
Why?
| | Hormone Replacement Therapy | 1 | 2022 | 106 | 0.170 |
Why?
| | Antigens, CD | 1 | 2024 | 555 | 0.170 |
Why?
| | Aurora Kinase A | 1 | 2021 | 62 | 0.170 |
Why?
| | Heterografts | 1 | 2021 | 143 | 0.160 |
Why?
| | Retrospective Studies | 6 | 2025 | 17066 | 0.160 |
Why?
| | Pheochromocytoma | 1 | 2021 | 58 | 0.160 |
Why?
| | Phthalazines | 1 | 2021 | 64 | 0.160 |
Why?
| | Adrenal Gland Diseases | 1 | 2020 | 5 | 0.160 |
Why?
| | Paraganglioma | 1 | 2021 | 53 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2025 | 748 | 0.160 |
Why?
| | Benzamides | 1 | 2021 | 224 | 0.160 |
Why?
| | Indolizines | 1 | 2019 | 13 | 0.150 |
Why?
| | Forkhead Box Protein M1 | 1 | 2019 | 8 | 0.150 |
Why?
| | Signal Transduction | 5 | 2025 | 5226 | 0.150 |
Why?
| | Immune System | 1 | 2021 | 179 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 881 | 0.150 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 210 | 0.150 |
Why?
| | Quinoxalines | 1 | 2019 | 65 | 0.150 |
Why?
| | Estrogens | 1 | 2022 | 380 | 0.150 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 99 | 0.150 |
Why?
| | Pituitary ACTH Hypersecretion | 1 | 2018 | 12 | 0.140 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 173 | 0.140 |
Why?
| | Gonadal Steroid Hormones | 1 | 2020 | 144 | 0.140 |
Why?
| | Lamin Type B | 1 | 2018 | 6 | 0.140 |
Why?
| | Cell Survival | 5 | 2025 | 1098 | 0.140 |
Why?
| | Gadolinium | 1 | 2019 | 84 | 0.140 |
Why?
| | Trans-Activators | 1 | 2021 | 405 | 0.140 |
Why?
| | NIMA-Related Kinases | 1 | 2018 | 9 | 0.140 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 154 | 0.140 |
Why?
| | Naphthyridines | 1 | 2018 | 20 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2020 | 339 | 0.130 |
Why?
| | Immunoblotting | 1 | 2018 | 300 | 0.130 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1499 | 0.130 |
Why?
| | Carcinogenesis | 1 | 2019 | 229 | 0.130 |
Why?
| | Protein Kinase Inhibitors | 2 | 2015 | 969 | 0.130 |
Why?
| | Aged | 7 | 2025 | 25913 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2018 | 341 | 0.130 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2020 | 199 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 635 | 0.130 |
Why?
| | Transcription Factors | 1 | 2025 | 1741 | 0.130 |
Why?
| | Microarray Analysis | 1 | 2017 | 117 | 0.130 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1253 | 0.130 |
Why?
| | Mutation | 3 | 2021 | 4089 | 0.130 |
Why?
| | Germ-Line Mutation | 1 | 2018 | 172 | 0.130 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1716 | 0.130 |
Why?
| | Kidney | 1 | 2025 | 1495 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2023 | 780 | 0.120 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2015 | 20 | 0.120 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 76 | 0.120 |
Why?
| | Contrast Media | 1 | 2019 | 488 | 0.120 |
Why?
| | Gonadotrophs | 2 | 2015 | 21 | 0.110 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 131 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 845 | 0.110 |
Why?
| | Phosphorylation | 1 | 2019 | 1732 | 0.110 |
Why?
| | Male | 11 | 2025 | 72315 | 0.110 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 623 | 0.110 |
Why?
| | Testosterone | 2 | 2023 | 419 | 0.100 |
Why?
| | Cell Movement | 2 | 2025 | 965 | 0.100 |
Why?
| | Young Adult | 3 | 2025 | 14105 | 0.090 |
Why?
| | Prospective Studies | 2 | 2023 | 7990 | 0.090 |
Why?
| | Hypogonadism | 1 | 2012 | 90 | 0.090 |
Why?
| | Antigens, Differentiation | 1 | 2011 | 77 | 0.090 |
Why?
| | Veterans | 1 | 2023 | 1603 | 0.080 |
Why?
| | Models, Molecular | 1 | 2015 | 1618 | 0.080 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 508 | 0.080 |
Why?
| | Glycoproteins | 1 | 2012 | 355 | 0.080 |
Why?
| | Quality of Life | 1 | 2022 | 3185 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 321 | 0.070 |
Why?
| | Reproduction | 1 | 2010 | 207 | 0.070 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2010 | 212 | 0.070 |
Why?
| | Cell Line | 3 | 2026 | 2882 | 0.070 |
Why?
| | Pyrazoles | 1 | 2012 | 509 | 0.070 |
Why?
| | Binding Sites | 2 | 2025 | 1329 | 0.070 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1462 | 0.070 |
Why?
| | Pyridines | 1 | 2012 | 605 | 0.070 |
Why?
| | Insulin Resistance | 1 | 2016 | 1241 | 0.070 |
Why?
| | Models, Biological | 2 | 2012 | 1821 | 0.060 |
Why?
| | Age Factors | 1 | 2014 | 3333 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2015 | 758 | 0.060 |
Why?
| | Cushing Syndrome | 1 | 2026 | 10 | 0.060 |
Why?
| | DNA, Neoplasm | 1 | 2006 | 163 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3863 | 0.060 |
Why?
| | Carcinoma, Papillary | 1 | 2006 | 79 | 0.060 |
Why?
| | Gene Silencing | 1 | 2006 | 205 | 0.060 |
Why?
| | Transcription Factor Pit-1 | 1 | 2025 | 26 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1795 | 0.060 |
Why?
| | Forkhead Box Protein O3 | 1 | 2025 | 18 | 0.060 |
Why?
| | Neoplasms | 1 | 2021 | 2875 | 0.060 |
Why?
| | p300-CBP Transcription Factors | 1 | 2025 | 26 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 851 | 0.060 |
Why?
| | Receptor, Notch1 | 1 | 2025 | 64 | 0.060 |
Why?
| | Protein Binding | 2 | 2025 | 2273 | 0.050 |
Why?
| | Insulin | 1 | 2016 | 2507 | 0.050 |
Why?
| | Ipilimumab | 1 | 2025 | 39 | 0.050 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2006 | 225 | 0.050 |
Why?
| | CTLA-4 Antigen | 1 | 2025 | 104 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 1 | 2025 | 192 | 0.050 |
Why?
| | Exercise | 1 | 2016 | 2201 | 0.050 |
Why?
| | Floxuridine | 1 | 2023 | 5 | 0.050 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2025 | 119 | 0.050 |
Why?
| | Triamcinolone Acetonide | 1 | 2023 | 20 | 0.050 |
Why?
| | Hepatic Artery | 1 | 2023 | 53 | 0.050 |
Why?
| | Databases, Genetic | 1 | 2024 | 248 | 0.050 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 1180 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2025 | 344 | 0.050 |
Why?
| | United States | 1 | 2020 | 15966 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2025 | 744 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 2006 | 345 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2025 | 427 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2023 | 135 | 0.050 |
Why?
| | RNA, Long Noncoding | 1 | 2024 | 177 | 0.050 |
Why?
| | Stress, Physiological | 2 | 2015 | 453 | 0.040 |
Why?
| | Follicle Stimulating Hormone | 1 | 2023 | 249 | 0.040 |
Why?
| | DNA Methylation | 1 | 2006 | 681 | 0.040 |
Why?
| | Aurora Kinase B | 1 | 2021 | 11 | 0.040 |
Why?
| | Chimerism | 1 | 2021 | 35 | 0.040 |
Why?
| | Neurons | 1 | 2010 | 1640 | 0.040 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 83 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2023 | 226 | 0.040 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 80 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 369 | 0.040 |
Why?
| | Drug Synergism | 1 | 2021 | 357 | 0.040 |
Why?
| | Precision Medicine | 1 | 2024 | 457 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 478 | 0.040 |
Why?
| | Zebrafish Proteins | 1 | 2023 | 311 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 610 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 737 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.030 |
Why?
| | Zebrafish | 1 | 2023 | 528 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2019 | 162 | 0.030 |
Why?
| | Cell Death | 1 | 2020 | 383 | 0.030 |
Why?
| | Remission Induction | 1 | 2018 | 307 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 354 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1886 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2026 | 2608 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 1137 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2015 | 148 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 124 | 0.030 |
Why?
| | Tumor Stem Cell Assay | 1 | 2015 | 34 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 675 | 0.030 |
Why?
| | Cytoprotection | 1 | 2015 | 55 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 361 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2025 | 2730 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2015 | 106 | 0.030 |
Why?
| | Gene Amplification | 1 | 2015 | 120 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2015 | 183 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2015 | 247 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 266 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3121 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2016 | 724 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 297 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 436 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3162 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 862 | 0.020 |
Why?
| | G2 Phase | 1 | 2012 | 39 | 0.020 |
Why?
| | Athletes | 1 | 2016 | 419 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2012 | 121 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2637 | 0.020 |
Why?
| | CpG Islands | 1 | 2012 | 165 | 0.020 |
Why?
| | Indoles | 1 | 2015 | 501 | 0.020 |
Why?
| | Sulfonamides | 1 | 2015 | 580 | 0.020 |
Why?
| | Cytoplasm | 1 | 2012 | 269 | 0.020 |
Why?
| | Genes, p53 | 1 | 2011 | 67 | 0.020 |
Why?
| | Cell Division | 1 | 2012 | 766 | 0.020 |
Why?
| | Olfactory Pathways | 1 | 2010 | 38 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 688 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1054 | 0.020 |
Why?
| | Neurogenesis | 1 | 2010 | 156 | 0.020 |
Why?
| | DNA Damage | 1 | 2011 | 430 | 0.020 |
Why?
| | Hypoxia | 1 | 2015 | 1199 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1257 | 0.020 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2006 | 21 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2006 | 9 | 0.020 |
Why?
| | Death-Associated Protein Kinases | 1 | 2006 | 10 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2006 | 42 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 168 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2006 | 186 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6048 | 0.010 |
Why?
| | Blood Glucose | 1 | 2016 | 2327 | 0.010 |
Why?
| | Cation Transport Proteins | 1 | 2006 | 118 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 983 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11679 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2016 | 2583 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22428 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2847 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 8265 | 0.010 |
Why?
|
|
Kiseljak-Vassiliades's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|